A team of UC Irvine researchers developed a mesenchymal stem cell-based treatment that can identify and kill bone cancer metastases in mice, the Daily Pilot reports.

Adam Rivadeneyra, MD, a sports medicine specialist with Irvine, Calif.-based Hoag Orthopedic Institute, spoke to Becker's Spine Review about his predictions for the field of biologics.

NanoFuse Biologics expanded into Asia after the successful use of its technology in a patient suffering from degenerative spine disease and osteoporosis in Thailand.

Biotechnology company DiscGenics treated the first Utahns in its nationwide clinical study of injectable disc cell therapy for degenerative disc disease.

The California Institute for Regenerative Medicine could close after awarding all allocated funds, The Scientist reports.

A federal court ordered that Sunrise, Fla.-based regenerative medicine companies US Stem Cell Clinic and US Stem Cell stop providing stem cell treatments to patients, according to the U.S. Department of Justice.

NervGen Pharma will use its developing drug technology for spinal cord injuries in a new multiple sclerosis program.

Biologics therapies have the promise to revolutionize orthopedics and sports medicine, but unauthorized operators pose a serious threat to emerging therapies.

Orthobiologics company Cerapedics appointed Patrick O'Connor to serve as vice president of clinical and market development.

Chinese biologics technology company WuXi Biologics is expanding its conjugation solution center to include commercial manufacturing later this year.

AlloSource partnered with Manufacturing USA in a new public-private initiative, the Advanced Regenerative Manufacturing Institute.

Granite Creek Capital Partners, a private investment firm in Chicago, invested in regenerative medicine company Royal Biologics.

Orthopedic and sports medicine technology company Ortho Regenerative Technologies unveiled Claude LeDuc as its new president and CEO, according to Biospace.

Regenerative Medicine Minnesota is a bipartisan effort to improve research, technology, education and patient access to regenerative medicine-based treatments.

Regenerative medicine has life-changing potential, but illegal actors are spurring a rash of regulatory activities.

Here are four key updates in about spinal biologics companies and advancements.

East Bay Health and Wellness Center, which offers chiropractic and wellness services in Walnut Creek, Calif., caught the ire of local CBS affiliate KPIX 5 for the unconventional way it markets unproven stem cell treatments.

NC Biomatrix BV is producing a biomaterial that will assist the treatment of intervertebral disc degeneration in a minimally invasive way, reports Innovation Origins.

Robert LaPrade, MD, PhD, a complex knee and sports medicine surgeon, joined Golden Valley, Minn.-based Twin Cities Orthopedics June 3. 

Ottawa, Canada-based biomaterials startup Spiderwort closed a $500,000 oversubscribed friends and family funding round, reports BetaKit.